Co Diagnostics Stock Investor Sentiment

CODX Stock  USD 1.01  0.05  4.72%   
Slightly above 61% of Co Diagnostics' investor base is looking to short. The analysis of overall sentiment of trading Co Diagnostics stock suggests that many investors are alarmed at this time. Co Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Co Diagnostics' earnings reports, geopolitical events, and overall market trends.
  
over three months ago at www.macroaxis.com         
Acquisition by Murphy Ted of 30000 shares of Co Diagnostics subject to Rule 16b-3
Macroaxis News
over three months ago at zacks.com         
GeneDx Holdings Corp. Reports Q2 Loss, Tops Revenue Estimates
zacks News
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POCOTC Diagnostics at ADLM 2024 in Chicago
Yahoo News
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
Yahoo News
over three months ago at news.google.com         
Co-Diagnostics, Inc. Sees Significant Increase in Short Interest - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Quest Diagnostics Stock Rating Upgraded by Citigroup - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Retirement Systems of Alabama Sells 280 Shares of Quest Diagnostics Incorporated - Defense World
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
Yahoo News
over three months ago at news.google.com         
Lucid Diagnostics Stock Price Up 3.4 percent - Defense World
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Yahoo News
over three months ago at news.google.com         
Co-Diagnostics Neutral Rating Reaffirmed at HC Wainwright - Defense World
Google News at Macroaxis
over three months ago at simplywall.st         
Heres Why Were Watching Co-Diagnostics Cash Burn Situation
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
Co-Diagnostics, Inc. Submits First FDA 510 Application for Co-Dx PCR Pro Platform
Yahoo News
over three months ago at news.google.com         
Personal CFO Solutions LLC Trims Stock Holdings in Quest Diagnostics Incorporated - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Co-Diagnostics to Post Q2 Earnings Whats in Store - Yahoo Canada Shine On
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. That information is available publicly through CODX media outlets and privately through word of mouth or via CODX internal channels. However, regardless of the origin, that massive amount of CODX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.

Co Diagnostics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.